1. Home
  2. RYAM vs ZVRA Comparison

RYAM vs ZVRA Comparison

Compare RYAM & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

N/A

Current Price

$11.46

Market Cap

491.8M

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$9.92

Market Cap

472.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RYAM
ZVRA
Founded
1926
2006
Country
United States
United States
Employees
2325
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
491.8M
472.9M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
RYAM
ZVRA
Price
$11.46
$9.92
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$14.00
$21.71
AVG Volume (30 Days)
1.2M
859.4K
Earning Date
01-01-0001
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
1.35
Revenue
$1,466,397,000.00
$106,470,000.00
Revenue This Year
$5.46
$333.64
Revenue Next Year
$8.02
$44.19
P/E Ratio
N/A
$7.71
Revenue Growth
N/A
350.91
52 Week Low
$3.35
$6.19
52 Week High
$11.28
$13.16

Technical Indicators

Market Signals
Indicator
RYAM
ZVRA
Relative Strength Index (RSI) 69.32 62.47
Support Level $7.09 $8.31
Resistance Level N/A $12.14
Average True Range (ATR) 0.74 0.44
MACD 0.20 0.16
Stochastic Oscillator 96.16 60.29

Price Performance

Historical Comparison
RYAM
ZVRA

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: